Oncopeptides AB (publ) reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was SEK 1.12 million. Net loss was SEK 71.03 million compared to SEK 98.59 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.16 SEK | -8.14% | -13.07% | -58.75% |
May. 30 | Oncopeptides Issues Warrants Under Loan Deal with European Investment Bank | MT |
May. 30 | Transcript : Oncopeptides AB, Q1 2024 Earnings Call, May 30, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-58.75% | 64.54M | |
+18.15% | 124B | |
+18.02% | 112B | |
+5.07% | 22.94B | |
-12.75% | 22.22B | |
-9.86% | 17.02B | |
-14.97% | 16.88B | |
-39.94% | 16.87B | |
+2.80% | 13.63B | |
+27.39% | 11.61B |
- Stock Market
- Equities
- ONCO Stock
- News Oncopeptides AB
- Oncopeptides AB Reports Earnings Results for the First Quarter Ended March 31, 2023